The largest database of trusted experimental protocols

Primary antibody for phospho akt

Manufactured by Cell Signaling Technology
Sourced in United States

The primary antibody for phospho-AKT is a reagent used in laboratory research. It specifically binds to the phosphorylated form of the AKT protein, which is a key signaling molecule involved in various cellular processes. This antibody can be used to detect and quantify the levels of activated AKT in biological samples, such as cell lysates or tissue extracts, using techniques like Western blotting or immunohistochemistry.

Automatically generated - may contain errors

2 protocols using primary antibody for phospho akt

1

Purification and Validation of S. japonicum SEA

Check if the same lab product or an alternative is used in the 5 most similar protocols
SEA of S. japonicum were obtained from Jiangsu Institute of Parasitic Diseases (China). SEA was sterile-filtered and endotoxin was removed with Polymyxin B agarose beads (Sigma, USA). Limulus amebocyte lysate assay kit (Lonza, Switzerland) was used to confirm the removal of endotoxins from the SEA as previously described [19 (link)]. Primary antibodies for FoxO3a, SKP2, P27 and AKT were purchased from Santa Cruz Biotechnology (USA, antibody dilution for Western blot of all antibodies from this company is 1:200). Primary antibody for phospho-AKT was purchased from Cell Signaling Technology (USA, antibody dilution for Western blot is 1:1000). All of the secondary antibodies were obtained from Santa Cruz Biotechnology (USA, antibody dilution is 1:2000). The staining kit for SA-β-Gal was purchased from GenMed Scientifics Inc (USA).
+ Open protocol
+ Expand
2

Insulin Signaling Pathway Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ten minutes prior to sacrifice, a subset of animals (n = 4–5 per group) underwent intra-peritoneal injection of insulin (10 U/kg) or saline vehicle. Liver and gastrocnemius muscle were harvested, and tissues were homogenized in buffer containing 0.25 m sucrose, 10 mm Tris–HCl, and 0.1 mm EGTA and protease inhibitors. For each sample, 30 μg of protein was transferred to nitrocellulose membranes, which were incubated overnight with primary antibody for phospho-AKT (1 : 000; Cell Signaling Technology, Danvers, MA, USA) and total AKT (1 : 1000; Cell Signaling Technology). Membranes were washed, incubated with horseradish protein-conjugated secondary antibody, and developed with ECL reagent (Pierce, Rockford, IL, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!